The possible synergistic effect of PRRT and PARP inhibition on tumor killing has been shown by us and others in different models, both in vitro and in vivo [6,7,8], yet the mechanism of action is not fully understood and discrepancies between findings exist; such as when comparing our NCI-H69 and CA20948 tumor models. Here, PARP1 is linked to neoplasm.